These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1914 related articles for article (PubMed ID: 30136202)
21. Expression of cancer stem cell markers in breast phyllodes tumor. Kim SI; Koo JS Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients. Pitule P; Cedikova M; Daum O; Vojtisek J; Vycital O; Hosek P; Treska V; Hes O; Kralickova M; Liska V Biomed Res Int; 2014; 2014():432139. PubMed ID: 24864242 [TBL] [Abstract][Full Text] [Related]
23. Prognostic Significance of Strati A; Nikolaou M; Georgoulias V; Lianidou ES Cells; 2019 Jun; 8(7):. PubMed ID: 31261917 [TBL] [Abstract][Full Text] [Related]
24. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer. Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma. Zhu B; Zhou L; Yu L; Wu S; Song W; Gong X; Wang D BMC Surg; 2017 Apr; 17(1):47. PubMed ID: 28431527 [TBL] [Abstract][Full Text] [Related]
26. CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinoma. Bartakova A; Michalova K; Presl J; Vlasak P; Kostun J; Bouda J J Obstet Gynaecol; 2018 Jan; 38(1):110-114. PubMed ID: 28816557 [TBL] [Abstract][Full Text] [Related]
27. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer. Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750 [TBL] [Abstract][Full Text] [Related]
28. Predictive value for lymph node metastasis of epithelial-mesenchymal transition and cancer stem cell marker expression in early gastric cancer. Nam KH; Yoon H; Lee K; Park DJ; Kim HH; Lee HS; Shin E Pathol Res Pract; 2017 Sep; 213(9):1221-1226. PubMed ID: 28595915 [TBL] [Abstract][Full Text] [Related]
29. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1). Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857 [TBL] [Abstract][Full Text] [Related]
30. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients. Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425 [TBL] [Abstract][Full Text] [Related]
31. Expression of PD-L1, cancer stem cell and epithelial-mesenchymal transition phenotype in non-small cell lung cancer. Koh YW; Han JH; Haam S Pathology; 2021 Feb; 53(2):239-246. PubMed ID: 33036771 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of putative cancer stem cell markers (CD24, CD44, CD133, and ALDH1) in human papillary thyroid carcinoma. Han SA; Jang JH; Won KY; Lim SJ; Song JY Pathol Res Pract; 2017 Aug; 213(8):956-963. PubMed ID: 28687160 [TBL] [Abstract][Full Text] [Related]
33. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis. Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258 [TBL] [Abstract][Full Text] [Related]
34. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer. Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454 [TBL] [Abstract][Full Text] [Related]
35. B7-H4 induces epithelial-mesenchymal transition and promotes colorectal cancer stemness. Feng Y; Yang Z; Zhang C; Che N; Liu X; Xuan Y Pathol Res Pract; 2021 Feb; 218():153323. PubMed ID: 33429327 [TBL] [Abstract][Full Text] [Related]
36. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer. Louhichi T; Ziadi S; Saad H; Dhiab MB; Mestiri S; Trimeche M Breast Cancer; 2018 Nov; 25(6):698-705. PubMed ID: 29845398 [TBL] [Abstract][Full Text] [Related]
38. Tumour budding and the expression of cancer stem cell marker aldehyde dehydrogenase 1 in nasopharyngeal carcinoma. Luo WR; Gao F; Li SY; Yao KT Histopathology; 2012 Dec; 61(6):1072-81. PubMed ID: 23020521 [TBL] [Abstract][Full Text] [Related]
39. [Expression tumor stem cell surface marker CD44 in gastric cancer and its significance]. Xie JW; Huang CM; Zheng CH; Li P; Wang JB; Lin JX; Lu J Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1107-12. PubMed ID: 24277411 [TBL] [Abstract][Full Text] [Related]
40. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer. Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]